GlassScriptPhysician profile
Chuong Nguyen
NPI 1396717690
$2,798.02
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $906 · 2021: $739 · 2022: $115 · 2023: $326 · 2024: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622 · Consulting Fee: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.22 |
| Consulting Fee | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $918.67 | 2019-2020 | |
| Boston Scientific Corporation | $794.45 | 2019-2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Medtronic, INC. | $439.51 | 2021-2023 | Surgipro Ll |
| Ethicon US, LLC | $155.92 | 2019-2021 | |
| Penumbra, INC. | $150.00 | 2021 | |
| Angiodynamics, INC. | $114.73 | 2022 | |
| Argon Medical Devices, INC. | $100.00 | 2023 | Cleaner |
| Medtronic Vascular, INC. | $88.61 | 2019 | |
| Abbvie INC. | $19.14 | 2023 | |
| Siemens Medical Solutions USA, INC. | $16.99 | 2023 | Naeotom Alpha, Multitom Rax, Artis Icono Floor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chuong Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.